We report the hybrid FDG PET/CT appearance of a biopsy-proven pancreatic metastasis from prostate cancer in a man with castrate-resistant metastatic disease. The common sites of metastases from prostate cancer are bone and locoregional lymph nodes. Pancreas is an atypical location of metastasis from prostate cancer. PET/CT in this case helped with the targeted pathologic confirmation to differentiate primary pancreatic tumor from an unusual metastasis from prostate cancer which in turn affected the clinical management.
showing cells with prominent nucleoli arranged in solid sheets without gland lumen formation. Axial skeleton and locoregional lymph nodes are the most frequent sites of tumor spread from prostate cancer. However, there have been reports of distant metastatic spread to other organs, including the lungs, liver, and adrenals. 1 Pancreas is an unusual site of metastasis from prostate cancer. Although there have been few reported cases of pancreatic metastasis from prostate cancer, none have included imaging findings with FDG PET/CT. [2] [3] [4] Metastases of prostate cancer accumulate FDG. [5] [6] [7] [8] To our knowledge, this interesting image case demonstrates the first illustration of FDG PET/CT appearance of a pancreatic metastasis from prostate cancer, highlighting the use of PET/ CT for targeted tissue confirmation to differentiate primary pancreatic tumor from an unusual site of metastasis.
